Pérez-Lara, Á.; Jahn, R.: Characterization of PROPPIN–Phosphoinositide Binding by Stopped-Flow Fluorescence Spectroscopy. In: Phosphoinositides (Hg. Botelho, R. J.). Humana, New York, NY (2021)

Rozanova, S.; Barkovits, K.; Nikolov, M.; Schmidt, C.; Urlaub, H.; Marcus, K.: Quantitative mass spectrometry-based proteomics: An overview. In: Quantitative Methods in Proteomics, 2. ed. Aufl., S. 85 - 116 (Hg. Marcus, K.; Eisenacher, M.; Sitek, B.). Humana Pr.; Springer, New York (2021)

Silbern, I.; Fang, P.; Ji, Y.; Lenz, C.; Urlaub, H.; Pan, K. T.: Relative quantification of phosphorylated and glycosylated peptides from the same sample using isobaric chemical labelling with a two-step enrichment strategy. In: Quantitative Methods in Proteomics, 2. ed Aufl., S. 185 - 203 (Hg. Marcus, K.; Eisenacher, M.; Sitek, B.). Humana Pr.; Springer, New York (2021)

Stegmann, K. M.; Dickmanns, A.; Heinen, N.; Gross, U.; Görlich, D.; Pfaender, S.; Dobbelstein, M.: N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replication. bioRxiv, 450163 (2021)

Söding, J.: Transcriptome- and genome-targeted cancer immunotherapy. (2021)

Quack, M.; Abel, B.; Merkt, F.; Hippler, H.; Vöhringer, P.; Wodtke, A. M.; Willitsch, S.: Preface to the special issue: The beauty of chemical reaction kinetics, a Festschrift in honour of Jürgen Troe. Molecular Physics 119 (17-18), e1984706 (2021)

Söding, J.: Do inhibitors targeted against mutant oncogenic kinases act via kinase degradation-induced immune activation? (2021)

Söding, J.: Proposed mechanism for thrombotic thrombocytopenia induced by adenovirus-based COVID-19 vaccines. (2021), 4 S.

Söding, J.: The immune activation model for targeted inhibitors of mutated oncogenic kinases. (2021)